SCHEMBL24728583

SCHEMBL24728583

CCCCC/C=C\C/C=C\CCCCCCCCN(CCO)CCCCCCCCCC(=O)ON(CC/C=C\CCCCC)CC/C=C\CCCCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.53
MGLL Q99685 1/20 0.51
CNR2 P34972 3/20 0.50
TRPV1 Q8NER1 2/20 0.50
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 3/20 0.48
F7 P08709 3/20 0.48
F3 P13726 3/20 0.48
PPARG P37231 2/20 0.48
PPARD Q03181 2/20 0.48
PPARA Q07869 2/20 0.48
HPGD P15428 2/20 0.48
DUSP3 P51452 1/20 0.48
PTPN7 P35236 1/20 0.48
FFAR1 O14842 1/20 0.48
LMNA P02545 1/20 0.48
FABP3 P05413 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP19A1 P11511 1/20 0.48
FABP4 P15090 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24728662 0.96 CNR1 (0.54) CNR1MGLLCNR2TRPV1ALDH1A1
SCHEMBL24728652 0.96 CNR2 (0.50) CNR1MGLLCNR2F7F3
SCHEMBL24728741 0.92 CNR2 (0.46) CNR1MGLLCNR2TRPV1
SCHEMBL27903374 0.91 CNR1 (0.62) CNR1MGLLCNR2TRPV1ALDH1A1
SCHEMBL24728762 0.90 CNR1 (0.55) CNR1MGLLCNR2TRPV1ALDH1A1
SCHEMBL24728770 0.89 ALDH1A1 (0.51) MGLLALDH1A1KDM4EF7F3
SCHEMBL24729086 0.89 EPHX2 (0.49) CNR2F7F3PPARGPPARD
SCHEMBL27639762 0.87 CNR1 (0.68) CNR1MGLLCNR2TRPV1ALDH1A1
SCHEMBL28646178 0.87 CNR2 (0.58) CNR1MGLLCNR2F7F3
SCHEMBL28819361 0.87 CNR2 (0.58) CNR1MGLLCNR2F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022168085-A1 LIPIDS SUITABLE FOR NUCLEIC ACID DELIVERY RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2022-08-11 WO disclosed